COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02169089
Recruitment Status : Recruiting
First Posted : June 20, 2014
Last Update Posted : March 7, 2018
University of Maryland, College Park
University of Toronto
Winthrop University
Information provided by (Responsible Party):
Sanjay Rajagopalan, University Hospitals Cleveland Medical Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021